Suraksha Diagnostic Launches Eastern India’s Largest Genomics Lab in Kolkata

The INR 22 crore investment significantly develops the region’s diagnostics infrastructure.

Suraksha Diagnostic has inaugurated one of Eastern India’s largest genomics laboratories in Kolkata. The INR 22 crore investment significantly develops the region’s diagnostics infrastructure.

An additional INR 46 crore investment is planned over the next two years to expand the lab further into one of Asia’s most advanced genomics facilities.

Equipped with Cytogenetics, Microarray Technology, Sanger Sequencing, and multiple Next-Generation Sequencers (NGS), the lab offers a comprehensive suite of genetic testing capabilities. These technologies enable predictive, preventive, and personalized healthcare solutions across various specialties, including fetal medicine, oncology, and rare diseases.

Focus on Regional Access and End-to-End Genomic Solutions

Dr. Somnath Chatterjee, Chairman and joint Managing Director of Suraksha Diagnostic, stated, “A huge transformation is sweeping across medicine today. At the heart of this revolution lies Genomics—unlocking the secrets of the Human Genome, enabling early diagnosis, predictive analytics, and personalized treatments. From Fetal Medicine to Oncology and Rare Diseases, genomic science is rewriting the future of healthcare. Suraksha Diagnostic is proud to be at the forefront of this revolution.”

Ritu Mittal, Joint Managing Director & CEO, added, “We provide end-to-end prenatal genetics solutions, offering comprehensive testing facilities. We aim to be a premium, aspirational choice for clinicians and families seeking the highest standards in fetal, reproductive, paediatric, and oncogenetics without the need to send samples out of the region or compromise on quality.”

The launch event was attended by Prof. Sukumar Mukherjee, a veteran rheumatologist and mentor at Suraksha Diagnostic.

Stay tuned for more such updates on Digital Health News